Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment
暂无分享,去创建一个
C. Fiehn | R. Waldherr | K. Andrassy | C Fiehn | K Andrassy | Y Hajjar | K Mueller | R Waldherr | A D Ho | K. Mueller | A. Ho | Y. Hajjar | Anthony D. Ho
[1] D. Gladman,et al. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. , 1995, The Journal of rheumatology.
[2] C. Jacob,et al. Prognostic factors in diffuse proliferative lupus nephritis. , 1999, The Journal of the Association of Physicians of India.
[3] S. Studenski,et al. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. , 1992, Archives of internal medicine.
[4] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[5] J. Balfe,et al. Correlation of renal histology with outcome in children with lupus nephritis. , 1986, Kidney international.
[6] J Thumboo,et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. , 1999, Arthritis and rheumatism.
[7] G. Hughes,et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. , 1999, Medicine.
[8] C. Vasconcelos,et al. Lupus nephritis: a retrospective review of 78 cases from a single center. , 2002, Clinical nephrology.
[9] M. Jadoul,et al. Cytotoxic therapy of lupus nephritis: recent developments. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] Y. Levy,et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. , 2002, Arthritis and rheumatism.
[11] D. Gladman,et al. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. , 1995, The Journal of rheumatology.
[12] D. Gladman,et al. Evolving spectrum of mortality and morbidity in SLE , 1999, Lupus.
[13] D. Nash,et al. Renal Disease: Classification and Atlas of Glomerular Diseases , 1983 .
[14] Joni K. Evans,et al. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. , 2001, Kidney international.
[15] D. Boumpas,et al. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] D. Gladman,et al. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. , 1997, The Journal of rheumatology.
[17] B. Haynes,et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. , 1983, Annals of internal medicine.
[18] J. Cameron,et al. Lupus Nephritis , 1959, Clinics in rheumatic diseases.
[19] S. Quaglini,et al. "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. , 1996, Kidney international.
[20] Role of pathology indices in the management of severe lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. , 1992, Kidney international.
[21] R Fischer,et al. Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation , 2001, Lupus.
[22] J. Cameron,et al. The very long-term prognosis and complications of lupus nephritis and its treatment. , 1999, QJM : monthly journal of the Association of Physicians.
[23] D. Sackett,et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.
[24] G. Hughes,et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period - A multicenter prospective study of 1,000 patients , 1999 .
[25] A. Steinberg,et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis , 1992, The Lancet.
[26] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[27] T. Kvien,et al. Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years. , 2001, The Journal of rheumatology.